HIDALGO MIRANDA, ALFREDO
CIENCIAS MÉDICAS · Nivel 3
Investigador Titular en Instituto Nacional de Medicina Genómica
My research is focused on the characterization of genomic alterations in human tumors. My group is currently working on the...
My research is focused on the characterization of genomic alterations in human tumors. My group is currently working on the analysis of Breast cancer and we are using several types of microarrays to analyze DNA copy number changes, gene and microRNA expression and polymorphisms in drug metabolizing genes. We are also collaborating with different institutions in the generation of a catalog of somatic alterations through next generation sequencing of whole genomes and exomes in these tumors.
Índice de visibilidad digital v1.0 · Mide qué tan completo está el perfil, no la calidad académica. Escala: 0–39 incompleto · 40–79 intermedio · 80–100 completo. ¿Cómo se calcula? · ¿Te falta un dato? Avísanos
| Nombre | ALFREDO HIDALGO MIRANDA |
|---|---|
| Área | MEDICINA Y CIENCIAS DE LA SALUD |
| Campo | CIENCIAS MÉDICAS |
| Disciplina | BIOLOGÍA HUMANA |
| Especialidad | GENOMICA, CANCER |
| CVU | 121473 |
| Institución | |
|---|---|
| Dependencia | SIN INFORMACIÓN |
| Entidad | CIUDAD DE MEXICO |
| Nivel | 3 |
| Vigencia | Inicio: 01/01/2021 |
| Fin: 31/12/2026 |
Evolución en el SNII
- Nivel I: 2005–2015
- Nivel III: 2016–2026
Últimas publicaciones Scopus
- 2026
- Sensitive detection of somatic mutations in GC-rich cancer gene promoters Nar Cancer · Vol. 8 Article
- Ancestry and somatic profile indicate acral melanoma origin and prognosis Nature · Vol. 651 Article
- 2025
- The microRNAs landscape of luminal B breast cancer cells in a three-dimensional microenvironment Hereditas · Vol. 162 Article
- Mitogenomic Alterations in Breast Cancer: Identification of Potential Biomarkers of Risk and Prognosis International Journal of Molecular Sciences · Vol. 26 Article
- 2024
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines BMC Cancer · Vol. 24 Article